The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
Subscribe To Our Newsletter & Stay Updated
